Delivery Order SPE2DB20D2104-SPE2DB25FMWET
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,168.39 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count packages). This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, with performance to be completed by July 18, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's broader...
- The Defense Logistics Agency awarded a $3,818.49 delivery order to AmerisourceBergen Drug Corp for Ondansetron ODT 8 mg tablets (30-count units) on September 9, 2025, with an ultimate completion date of September 10, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's broader pharmaceutical supply relationship with the agency. The product will be performed at the vendor's Conshohocken, Pennsylvania...
- The Defense Logistics Agency awarded a $2,461.52 delivery order to AmerisourceBergen Drug Corp for Ondansetron ODT 8 mg tablets in a 30-tablet quantity, with completion scheduled for August 26, 2025. This firm fixed-price contract was competitively awarded with no set-aside designation and represents a child order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The pharmaceutical product will be performed and delivered from the contractor's...
- The Defense Logistics Agency awarded a $2,487.53 delivery order to AmerisourceBergen Drug Corp for Ondansetron ODT 8 mg tablets (30-count supply) on August 21, 2025, with completion targeted for August 22, 2025. This firm fixed-price, non-set-aside delivery order is being performed in Conshohocken, Pennsylvania, the vendor's corporate headquarters location. The award represents a small-value transaction within AmerisourceBergen's broader pharmaceutical supply portfolio to federal customers. This...
- The Defense Logistics Agency awarded a $4,445.95 delivery order to AmerisourceBergen Drug Corp for Ondansetron ODT (orally disintegrating tablet) 4 mg tablets in quantities of 30, with an ultimate completion date of June 20, 2025. This competitively awarded, firm fixed-price contract reflects a non-set-aside procurement and represents a continuation of AmerisourceBergen's ongoing pharmaceutical supply relationship with DLA. The contract specifies performance at AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a $1,293.48 firm fixed price delivery order to AmerisourceBergen Drug Corp for Ondansetron ODT 4 mg tablets (30-count) with a completion date of September 19, 2025. This competitively awarded, non-set-aside contract represents a single delivery order against AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The work will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $13.45K to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count units) on July 25, 2025, with an ultimate completion date of July 28, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999.99M ceiling value and extends...
- The Defense Logistics Agency awarded a delivery order valued at $3,192.18 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count units) on August 27, 2025, with completion anticipated by August 28, 2025. This firm fixed price delivery order represents a non-competitive, non-set-aside award under AmerisourceBergen's existing contract vehicle with DLA. The pharmaceutical product will be delivered to the company's headquarters location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $4,958.04 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count units). This competitively awarded, firm fixed-price delivery order was issued on July 23, 2025, with an ultimate completion date of July 24, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this procurement. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $5,660.39 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 MG tablets (30-count packages) with a firm fixed price structure. The contract, awarded July 31, 2025, represents a non-set-aside, competitively awarded delivery order with an ultimate completion date of August 1, 2025. Performance will be executed from the vendor's location in Conshohocken, Pennsylvania, the company's corporate headquarters. This...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FMWETDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,563.68 to AmerisourceBergen Drug Corp for Ondansetron ODT 4 mg tablets (30-count units) on July 23, 2025, with completion targeted for July 24, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply contract vehicle. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026 that supports global pharmaceutical supply requirements for military healthcare programs. AmerisourceBergen, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal vendor supplying brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive portfolio of federal contracts demonstrates its capability to meet competitive procurement requirements for diverse medical supply needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 7/23/25 |